IBDEI0S7 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,37259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37259,1,3,0)
 ;;=3^Acquired absence of left leg below knee
 ;;^UTILITY(U,$J,358.3,37259,1,4,0)
 ;;=4^Z89.512
 ;;^UTILITY(U,$J,358.3,37259,2)
 ;;=^5063567
 ;;^UTILITY(U,$J,358.3,37260,0)
 ;;=Z89.611^^106^1586^22
 ;;^UTILITY(U,$J,358.3,37260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37260,1,3,0)
 ;;=3^Acquired absence of right leg above knee
 ;;^UTILITY(U,$J,358.3,37260,1,4,0)
 ;;=4^Z89.611
 ;;^UTILITY(U,$J,358.3,37260,2)
 ;;=^5063572
 ;;^UTILITY(U,$J,358.3,37261,0)
 ;;=Z89.612^^106^1586^7
 ;;^UTILITY(U,$J,358.3,37261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37261,1,3,0)
 ;;=3^Acquired absence of left leg above knee
 ;;^UTILITY(U,$J,358.3,37261,1,4,0)
 ;;=4^Z89.612
 ;;^UTILITY(U,$J,358.3,37261,2)
 ;;=^5063573
 ;;^UTILITY(U,$J,358.3,37262,0)
 ;;=Z89.622^^106^1586^6
 ;;^UTILITY(U,$J,358.3,37262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37262,1,3,0)
 ;;=3^Acquired absence of left hip joint
 ;;^UTILITY(U,$J,358.3,37262,1,4,0)
 ;;=4^Z89.622
 ;;^UTILITY(U,$J,358.3,37262,2)
 ;;=^5063576
 ;;^UTILITY(U,$J,358.3,37263,0)
 ;;=Z89.621^^106^1586^20
 ;;^UTILITY(U,$J,358.3,37263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37263,1,3,0)
 ;;=3^Acquired absence of right hip joint
 ;;^UTILITY(U,$J,358.3,37263,1,4,0)
 ;;=4^Z89.621
 ;;^UTILITY(U,$J,358.3,37263,2)
 ;;=^5063575
 ;;^UTILITY(U,$J,358.3,37264,0)
 ;;=R47.01^^106^1587^1
 ;;^UTILITY(U,$J,358.3,37264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37264,1,3,0)
 ;;=3^Aphasia
 ;;^UTILITY(U,$J,358.3,37264,1,4,0)
 ;;=4^R47.01
 ;;^UTILITY(U,$J,358.3,37264,2)
 ;;=^5019488
 ;;^UTILITY(U,$J,358.3,37265,0)
 ;;=I69.320^^106^1587^2
 ;;^UTILITY(U,$J,358.3,37265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37265,1,3,0)
 ;;=3^Aphasia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,37265,1,4,0)
 ;;=4^I69.320
 ;;^UTILITY(U,$J,358.3,37265,2)
 ;;=^5007491
 ;;^UTILITY(U,$J,358.3,37266,0)
 ;;=I69.120^^106^1587^3
 ;;^UTILITY(U,$J,358.3,37266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37266,1,3,0)
 ;;=3^Aphasia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,37266,1,4,0)
 ;;=4^I69.120
 ;;^UTILITY(U,$J,358.3,37266,2)
 ;;=^5007427
 ;;^UTILITY(U,$J,358.3,37267,0)
 ;;=I69.020^^106^1587^4
 ;;^UTILITY(U,$J,358.3,37267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37267,1,3,0)
 ;;=3^Aphasia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,37267,1,4,0)
 ;;=4^I69.020
 ;;^UTILITY(U,$J,358.3,37267,2)
 ;;=^5007395
 ;;^UTILITY(U,$J,358.3,37268,0)
 ;;=I69.820^^106^1587^5
 ;;^UTILITY(U,$J,358.3,37268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37268,1,3,0)
 ;;=3^Aphasia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,37268,1,4,0)
 ;;=4^I69.820
 ;;^UTILITY(U,$J,358.3,37268,2)
 ;;=^5007522
 ;;^UTILITY(U,$J,358.3,37269,0)
 ;;=I69.220^^106^1587^6
 ;;^UTILITY(U,$J,358.3,37269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37269,1,3,0)
 ;;=3^Aphasia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,37269,1,4,0)
 ;;=4^I69.220
 ;;^UTILITY(U,$J,358.3,37269,2)
 ;;=^5007459
 ;;^UTILITY(U,$J,358.3,37270,0)
 ;;=I69.290^^106^1587^11
 ;;^UTILITY(U,$J,358.3,37270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37270,1,3,0)
 ;;=3^Apraxia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,37270,1,4,0)
 ;;=4^I69.290
 ;;^UTILITY(U,$J,358.3,37270,2)
 ;;=^5007484
 ;;^UTILITY(U,$J,358.3,37271,0)
 ;;=I69.390^^106^1587^7
 ;;^UTILITY(U,$J,358.3,37271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37271,1,3,0)
 ;;=3^Apraxia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,37271,1,4,0)
 ;;=4^I69.390
 ;;^UTILITY(U,$J,358.3,37271,2)
 ;;=^5007515
 ;;^UTILITY(U,$J,358.3,37272,0)
 ;;=I69.190^^106^1587^8
 ;;^UTILITY(U,$J,358.3,37272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37272,1,3,0)
 ;;=3^Apraxia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,37272,1,4,0)
 ;;=4^I69.190
 ;;^UTILITY(U,$J,358.3,37272,2)
 ;;=^5007452
 ;;^UTILITY(U,$J,358.3,37273,0)
 ;;=I69.090^^106^1587^9
 ;;^UTILITY(U,$J,358.3,37273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37273,1,3,0)
 ;;=3^Apraxia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,37273,1,4,0)
 ;;=4^I69.090
 ;;^UTILITY(U,$J,358.3,37273,2)
 ;;=^5007420
 ;;^UTILITY(U,$J,358.3,37274,0)
 ;;=I69.890^^106^1587^10
 ;;^UTILITY(U,$J,358.3,37274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37274,1,3,0)
 ;;=3^Apraxia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,37274,1,4,0)
 ;;=4^I69.890
 ;;^UTILITY(U,$J,358.3,37274,2)
 ;;=^5007546
 ;;^UTILITY(U,$J,358.3,37275,0)
 ;;=I69.393^^106^1587^12
 ;;^UTILITY(U,$J,358.3,37275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37275,1,3,0)
 ;;=3^Ataxia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,37275,1,4,0)
 ;;=4^I69.393
 ;;^UTILITY(U,$J,358.3,37275,2)
 ;;=^5007518
 ;;^UTILITY(U,$J,358.3,37276,0)
 ;;=I69.193^^106^1587^13
 ;;^UTILITY(U,$J,358.3,37276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37276,1,3,0)
 ;;=3^Ataxia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,37276,1,4,0)
 ;;=4^I69.193
 ;;^UTILITY(U,$J,358.3,37276,2)
 ;;=^5007455
 ;;^UTILITY(U,$J,358.3,37277,0)
 ;;=I69.293^^106^1587^16
 ;;^UTILITY(U,$J,358.3,37277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37277,1,3,0)
 ;;=3^Ataxia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,37277,1,4,0)
 ;;=4^I69.293
 ;;^UTILITY(U,$J,358.3,37277,2)
 ;;=^5007487
 ;;^UTILITY(U,$J,358.3,37278,0)
 ;;=I69.093^^106^1587^14
 ;;^UTILITY(U,$J,358.3,37278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37278,1,3,0)
 ;;=3^Ataxia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,37278,1,4,0)
 ;;=4^I69.093
 ;;^UTILITY(U,$J,358.3,37278,2)
 ;;=^5007423
 ;;^UTILITY(U,$J,358.3,37279,0)
 ;;=I69.893^^106^1587^15
 ;;^UTILITY(U,$J,358.3,37279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37279,1,3,0)
 ;;=3^Ataxia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,37279,1,4,0)
 ;;=4^I69.893
 ;;^UTILITY(U,$J,358.3,37279,2)
 ;;=^5007549
 ;;^UTILITY(U,$J,358.3,37280,0)
 ;;=I69.31^^106^1587^17
 ;;^UTILITY(U,$J,358.3,37280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37280,1,3,0)
 ;;=3^Cognitive deficits following cerebral infarction
 ;;^UTILITY(U,$J,358.3,37280,1,4,0)
 ;;=4^I69.31
 ;;^UTILITY(U,$J,358.3,37280,2)
 ;;=^5007490
 ;;^UTILITY(U,$J,358.3,37281,0)
 ;;=I69.11^^106^1587^18
 ;;^UTILITY(U,$J,358.3,37281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37281,1,3,0)
 ;;=3^Cognitive deficits following nontraumatic intcrbl hemorrhage
 ;;^UTILITY(U,$J,358.3,37281,1,4,0)
 ;;=4^I69.11
 ;;^UTILITY(U,$J,358.3,37281,2)
 ;;=^5007426
 ;;^UTILITY(U,$J,358.3,37282,0)
 ;;=I69.01^^106^1587^19
 ;;^UTILITY(U,$J,358.3,37282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37282,1,3,0)
 ;;=3^Cognitive deficits following ntrm subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,37282,1,4,0)
 ;;=4^I69.01
 ;;^UTILITY(U,$J,358.3,37282,2)
 ;;=^5007394
 ;;^UTILITY(U,$J,358.3,37283,0)
 ;;=I69.81^^106^1587^21
 ;;^UTILITY(U,$J,358.3,37283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37283,1,3,0)
 ;;=3^Cognitive deficits following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,37283,1,4,0)
 ;;=4^I69.81
 ;;^UTILITY(U,$J,358.3,37283,2)
 ;;=^5007521
 ;;^UTILITY(U,$J,358.3,37284,0)
 ;;=I69.21^^106^1587^20
 ;;^UTILITY(U,$J,358.3,37284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37284,1,3,0)
 ;;=3^Cognitive deficits following oth ntrm intcrn hemorrhage
 ;;^UTILITY(U,$J,358.3,37284,1,4,0)
 ;;=4^I69.21
 ;;^UTILITY(U,$J,358.3,37284,2)
 ;;=^5007458
 ;;^UTILITY(U,$J,358.3,37285,0)
 ;;=I69.391^^106^1587^22
 ;;^UTILITY(U,$J,358.3,37285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37285,1,3,0)
 ;;=3^Dysphagia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,37285,1,4,0)
 ;;=4^I69.391
 ;;^UTILITY(U,$J,358.3,37285,2)
 ;;=^5007516
 ;;^UTILITY(U,$J,358.3,37286,0)
 ;;=I69.191^^106^1587^23
 ;;^UTILITY(U,$J,358.3,37286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37286,1,3,0)
 ;;=3^Dysphagia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,37286,1,4,0)
 ;;=4^I69.191
 ;;^UTILITY(U,$J,358.3,37286,2)
 ;;=^5007453
 ;;^UTILITY(U,$J,358.3,37287,0)
 ;;=I69.291^^106^1587^25
 ;;^UTILITY(U,$J,358.3,37287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37287,1,3,0)
 ;;=3^Dysphagia following oth nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,37287,1,4,0)
 ;;=4^I69.291
 ;;^UTILITY(U,$J,358.3,37287,2)
 ;;=^5007485
 ;;^UTILITY(U,$J,358.3,37288,0)
 ;;=I69.091^^106^1587^24
 ;;^UTILITY(U,$J,358.3,37288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37288,1,3,0)
 ;;=3^Dysphagia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,37288,1,4,0)
 ;;=4^I69.091
 ;;^UTILITY(U,$J,358.3,37288,2)
 ;;=^5007421
 ;;^UTILITY(U,$J,358.3,37289,0)
 ;;=I69.891^^106^1587^26
 ;;^UTILITY(U,$J,358.3,37289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37289,1,3,0)
 ;;=3^Dysphagia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,37289,1,4,0)
 ;;=4^I69.891
 ;;^UTILITY(U,$J,358.3,37289,2)
 ;;=^5007547
 ;;^UTILITY(U,$J,358.3,37290,0)
 ;;=I69.321^^106^1587^27
 ;;^UTILITY(U,$J,358.3,37290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37290,1,3,0)
 ;;=3^Dysphasia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,37290,1,4,0)
 ;;=4^I69.321
 ;;^UTILITY(U,$J,358.3,37290,2)
 ;;=^5007492
 ;;^UTILITY(U,$J,358.3,37291,0)
 ;;=I69.121^^106^1587^28
 ;;^UTILITY(U,$J,358.3,37291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37291,1,3,0)
 ;;=3^Dysphasia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,37291,1,4,0)
 ;;=4^I69.121
 ;;^UTILITY(U,$J,358.3,37291,2)
 ;;=^5007428
 ;;^UTILITY(U,$J,358.3,37292,0)
 ;;=I69.021^^106^1587^29
 ;;^UTILITY(U,$J,358.3,37292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37292,1,3,0)
 ;;=3^Dysphasia following nontraumatic subarachnoid hemorrhage
